Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.

Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment

Open access
Liu, Shan, Gao, Jiguo, Zhu, Mingqin, Liu, Kangding, Zhang, Hong-Liang · 2020 · Molecular Neurobiology

Abstract

Understanding how gut flora influences gut-brain communications has been the subject of significant research over the past decade. The broadening of the term “microbiota-gut-brain axis” from “gut-brain axis” underscores a bidirectional communication system between the gut and the brain. The microbiota-gut-brain axis involves metabolic, endocrine, neural, and immune pathways which are crucial for the maintenance of brain homeostasis. Alterations in the composition of gut microbiota are associated with multiple neuropsychiatric disorders. Although a causal relationship between gut dysbiosis and neural dysfunction remains elusive, emerging evidence indicates that gut dysbiosis may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, and insulin resistance in the pathogenesis of Alzheimer’s disease (AD). Illustration of the mechanisms underlying the regulation by gut microbiota may pave the way for developing novel therapeutic strategies for AD. In this narrative review, we provide an overview of gut microbiota and their dysregulation in the pathogenesis of AD. Novel insights into the modification of gut microbiota composition as a preventive or therapeutic approach for AD are highlighted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-020-02073-3

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Key factors in the pathogenesis of AD. amyloid plaques and intracellular NFTs, neuroinflammation, mitochondrial dysfunction, OS, IR, and chronic cerebral hypoperfusion are the main causes of AD development. These factors are related to each other directly or indirectly. Cerebral hypoperfusion due to advanced atherosclerosis or endothelial dysfunction, IR, and mitochondrial dysfunction lead to an elevation in ROS levels which results in overexpression and increased processing of APP, hyperphosphorylation of tau, and NFT pathology leading to neuronal death. Aβ, TBI, and infections are some of the factors that can elicit inflammation. Abbreviations: Aβ amyloid-beta, AD Alzheimer’s disease, APP amyloid precursor protein, IR insulin resistance, NFT neurofibrillary tangle, OS oxidative stress, ROS reactive oxygen species, TBI traumatic brain injury
Fig. 1 Key factors in the pathogenesis of AD. amyloid plaques and intracellular NFTs, neuroinflammation, mitochondrial dysfunction, OS, IR, and chronic cerebral hypoperfusion are the main causes of AD development. These factors are related to each other directly or indirectly. Cerebral hypoperfusion due to advanced atherosclerosis or endothelial dysfunction, IR, and mitochondrial dysfunction lead to an elevation in ROS levels which results in overexpression and increased processing of APP, hyperphosphorylation of tau, and NFT pathology leading to neuronal death. Aβ, TBI, and infections are some of the factors that can elicit inflammation. Abbreviations: Aβ amyloid-beta, AD Alzheimer’s disease, APP amyloid precursor protein, IR insulin resistance, NFT neurofibrillary tangle, OS oxidative stress, ROS reactive oxygen species, TBI traumatic brain injuryCC BY · PubMed Central
Fig. 2 Communication between gut microbiota and the brain. Communication pathways between gut microbiota and the brain include metabolic, endocrine, neural, and immunological pathways which can work independently or cooperatively: (1) gut microbiota metabolites, including SCFAs, neurotransmitters, and amyloids, may reach the brain to regulate neurological function; (2) gut microbiota interacts with the HPA axis, regulating brain function and gut microbiota composition; (3) direct activation of the vagus nerve from the enteric nervous system is transmitted to the brain; (4) MAMPs such as LPS can activate both the peripheral and the central immune system. Abbreviations: ACTH adrenocorticotropic hormone, CRH corticotropin-releasing hormone, EC enterochromaffin cell, EEC enteroendocrine cell, HPA hypothalamus-pituitary-adrenal, LPS lipopolysaccharide, MAMPs microbial associated molecular patterns, SCFAs short-chain fatty acids, VN vagus nerve
Fig. 2 Communication between gut microbiota and the brain. Communication pathways between gut microbiota and the brain include metabolic, endocrine, neural, and immunological pathways which can work independently or cooperatively: (1) gut microbiota metabolites, including SCFAs, neurotransmitters, and amyloids, may reach the brain to regulate neurological function; (2) gut microbiota interacts with the HPA axis, regulating brain function and gut microbiota composition; (3) direct activation of the vagus nerve from the enteric nervous system is transmitted to the brain; (4) MAMPs such as LPS can activate both the peripheral and the central immune system. Abbreviations: ACTH adrenocorticotropic hormone, CRH corticotropin-releasing hormone, EC enterochromaffin cell, EEC enteroendocrine cell, HPA hypothalamus-pituitary-adrenal, LPS lipopolysaccharide, MAMPs microbial associated molecular patterns, SCFAs short-chain fatty acids, VN vagus nerveCC BY · PubMed Central
Fig. 3 Impact of gut dysbiosis on AD. Gut dysbiosis induces the decrease of beneficial substances (such as SCFAs and H2) and the increase of harmful substances (such as amyloids and TMAO), which causes the intestinal mucosal barrier and BBB to become permeable, activates peripheral immune responses, and increases peripheral and central OS levels. Finally, gut dysbiosis contributes to AD pathology progression by increasing amyloid plaque formation, neuroinflammation, SGs, and IR. Arrows indicate the direction of the effect. Yellow arrows with dashed lines indicate that no studies have explored this putative relationship yet in the AD-gut microbiome field. Abbreviations: AD Alzheimer’s disease, BAs bile acids, BBB blood-brain barrier, LPS lipopolysaccharide, H2 hydrogen, IR insulin resistance, OS oxidative stress, PRRs pattern-recognition receptors, SCFAs short-chain fatty acids, SGs stress granules, TMAO trimethylamine N-oxide
Fig. 3 Impact of gut dysbiosis on AD. Gut dysbiosis induces the decrease of beneficial substances (such as SCFAs and H2) and the increase of harmful substances (such as amyloids and TMAO), which causes the intestinal mucosal barrier and BBB to become permeable, activates peripheral immune responses, and increases peripheral and central OS levels. Finally, gut dysbiosis contributes to AD pathology progression by increasing amyloid plaque formation, neuroinflammation, SGs, and IR. Arrows indicate the direction of the effect. Yellow arrows with dashed lines indicate that no studies have explored this putative relationship yet in the AD-gut microbiome field. Abbreviations: AD Alzheimer’s disease, BAs bile acids, BBB blood-brain barrier, LPS lipopolysaccharide, H2 hydrogen, IR insulin resistance, OS oxidative stress, PRRs pattern-recognition receptors, SCFAs short-chain fatty acids, SGs stress granules, TMAO trimethylamine N-oxideCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 173 references

Cited by

See all 516

Metadata

Authors
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L.
Affiliations
  • Jilin University (CN)
  • Mayo Clinic (US)
Corresponding author
Liu, Kangding
Venue
Molecular Neurobiology
Published
2020-08-23
Volume
57
Issue
12
Pages
5026-5043
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W3080830493
Cited by
516
References
173
Citations by year
2026: 87 · 2025: 136 · 2024: 108 · 2023: 77 · 2022: 62 · 2021: 42 · 2020: 4
FWCI
4.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Neurobiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81771299)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
gut microbiota, dysbiosis, Alzheimer's disease, microbiota-gut-brain axis, amyloid-beta aggregation, neuroinflammation, oxidative stress, insulin resistance, Alzheimer's disease pathogenesis, Alzheimer's disease treatment, neuropsychiatric disorders
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Animals, Brain, Humans, Insulin Resistance, Oxidative Stress, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment. https://app.cochat.ai/papers/10.1007/s12035-020-02073-3
The paper
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020). Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment. Molecular Neurobiology. https://doi.org/10.1007/s12035-020-02073-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.